These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2702023)

  • 1. [New trends in the prevention of ischemic heart disease].
    Cortese C; Farinaro E; Mancini M
    Ann Ital Med Int; 1989; 4(2):138-42. PubMed ID: 2702023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
    BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities and strategies for prevention of ischemic heart disease. Risk factors, trials, mass and individual strategies].
    Menotti A
    G Ital Cardiol; 1989 Sep; 19(9):770-7; discussion 778-86. PubMed ID: 2612823
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of the cooperative program of multifactorial prevention of ischemic heart disease (results of the 3-year study)].
    Domarkene SB; Baubinene AV; Chazova LV; Kalinina AM; Meĭmanaliev TS; Shleĭfer EA; Davydova LI; Nikolenko EIa; Makhmudov BKh; Karimov TM
    Kardiologiia; 1990 Apr; 30(4):95-8. PubMed ID: 2203931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Theoretical bases of health education in the primary prevention of coronary cardiopathy].
    Menotti A
    G Ital Cardiol; 1983; 13(4):216-21. PubMed ID: 6884662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride, high density lipoprotein, and coronary heart disease.
    Consens Statement; 1992 Feb 26-28; 10(2):1-28. PubMed ID: 1286136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease and coronary disease risk factors in black populations in underdeveloped countries: the case for primordial prevention.
    Watkins LO
    Am Heart J; 1984 Sep; 108(3 Pt 2):850-62. PubMed ID: 6475755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of the 5-year program of multi-factorial prevention of ischemic heart disease in men].
    Meĭmanaliev TS; Shleĭfer EA; Madaminov IaK; Gil'fanova VSh; Aĭtmurzaeva GT; Finger EM; Ismailova ChS; Koshaliev EK; Iaroslavtseva OS; Podgurskaia LP
    Sov Med; 1990; (12):57-9. PubMed ID: 2151491
    [No Abstract]   [Full Text] [Related]  

  • 11. Diet and coronary heart disease.
    Stamler J
    Biometrics; 1982 Mar; 38 Suppl():95-118. PubMed ID: 7046825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary prevention of ischemic heart disease].
    Kruglov VA
    Med Sestra; 1987 Jul; 46(7):12-6. PubMed ID: 3657467
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
    Unal B; Critchley JA; Capewell S
    BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol".
    Jukema JW; Simoons ML
    Acta Cardiol; 1999 Jun; 54(3):163-8. PubMed ID: 10478274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking, physical activity, and other predictors of endurance and heart rate response to exercise in asymptomatic hypercholesterolemic men. The Lipid Research Clinics Coronary Primary Prevention Trial.
    Gordon DJ; Leon AS; Ekelund LG; Sopko G; Probstfield JL; Rubenstein C; Sheffield LT
    Am J Epidemiol; 1987 Apr; 125(4):587-600. PubMed ID: 3826039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential population impact of the UK government strategy for reducing the burden of coronary heart disease in England: comparing primary and secondary prevention strategies.
    Gemmell I; Heller RF; Payne K; Edwards R; Roland M; Durrington P
    Qual Saf Health Care; 2006 Oct; 15(5):339-43. PubMed ID: 17074870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future perspectives in the prevention of coronary heart disease.
    Pyörälä K
    Cor Vasa; 1991; 33(2):91-102. PubMed ID: 1889212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fiber and coronary heart disease in middle-aged hypercholesterolemic men.
    Humble CG; Malarcher AM; Tyroler HA
    Am J Prev Med; 1993; 9(4):197-202. PubMed ID: 8398218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multifactor primary prevention trial in Göteborg, Sweden.
    Wilhelmsen L; Berglund G; Elmfeldt D; Tibblin G; Wedel H; Pennert K; Vedin A; Wilhelmsson C; Werkö L
    Eur Heart J; 1986 Apr; 7(4):279-88. PubMed ID: 3720755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.